Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration
Sign Up to like & getrecommendations! Published in 2019 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-019-04360-9
Abstract: PurposeTo assess the morphological and functional outcome and stability of the “treat and extend” protocol using aflibercept compared to ranibizumab for the treatment of eyes with neovascular age-related macular degeneration.Patients and methodsThis retrospective study included… read more here.
Keywords: age related; treatment; extend protocol; group ... See more keywords
A treat and extend protocol with Aflibercept for cystoid macular oedema secondary to central retinal vein occlusion – an 18-month prospective cohort study
Sign Up to like & getrecommendations! Published in 2020 at "BMC Ophthalmology"
DOI: 10.1186/s12886-020-01346-8
Abstract: Background To evaluate the safety and efficacy of a treat-and-extend protocol of aflibercept for cystoid macular oedema (CMO) secondary to central retinal vein occlusion (CRVO). Methods Twenty patients with CMO secondary to CRVO were included… read more here.
Keywords: protocol aflibercept; extend protocol; aflibercept cystoid; study ... See more keywords